HOUSTON (AP) — HOUSTON (AP) — Bellicum Pharmacueticals Inc. (BLCM) on Tuesday reported a loss of $763,000 in its third quarter.
The Houston-based company said it had a loss of 2 cents per share.
The drug developer posted revenue of $1 million in the period.
The company's shares closed at 10 cents. A year ago, they were trading at $1.02.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLCM at https://www.zacks.com/ap/BLCM